WHO世界卫生组织:2017年8月-2021年12月不合格和伪造医疗产品的全球监测和监测系统活动报告(英文版).pdf |
下载文档 |
资源简介
Access to safe, effective medical products is paramount for global health. This report describes a critical role of WHO in ensuring the quality and safety of medical products, particularly in LMIC. The report signals the alarming rise in the number of reported incidents of SF medical products, including a wide range of essential medicines,
such as antimicrobials, oncology medicines and vaccines. During the period covered, 877 incidents were recorded, with an average annual increase of 3
本文档仅能预览20页